Am. J. Respir. Cell Mol. Biol., Volume 20, Number 4, April, 1999 834-841

Leukemia Inhibitory Factor (LIF) and LIF Receptor in Human Lung
Distribution and Regulation of LIF Release

Darryl A. Knight,^* Carmen P. Lydell, Danyi Zhou, Tracey D. Weir, R. Robert Schellenberg, and Tony R. Bai

University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, British Columbia, Canada

The distribution and regulation of leukemia inhibitory factor (LIF) and its receptor (LIFR) in human lung tissue is unknown. We recently found that LIF was immunolocalized to several cell types in human airways, and that exogenous LIF modulated neural and contractile responses of explanted airways. The present study aimed to determine the cellular distribution and regulation of gene transcripts for LIF and LIFR in human lung, and measured the release of LIF in response to anti-immunoglobulin (Ig)E, interleukin (IL)-1, and IL-6. Exposure of human lung to IL-1 (100 pg/ml) resulted in the rapid induction of LIF messenger RNA (mRNA) (1 h) and subsequent protein release (6 h). Similar results were observed when lung tissue was exposed to anti-IgE (6 U/ml). Gene transcripts for LIF were observed in nine pulmonary cell types, with the greatest expression occurring in fibroblasts. LIFR transcripts were also widely expressed in these cell types. In cultures of nontransformed epithelial cells, lung fibroblasts, and airway smooth-muscle cells, IL-1 (100 pg/ml) induced the rapid accumulation of LIF mRNA and protein release, with fibroblasts liberating the greatest amount. IL-6 also induced the expression of LIF mRNA and release of LIF in airway smooth-muscle cells, whereas exogenous LIF itself had no effect. Expression of LIFR mRNA was not influenced by exposure to IL-1 or LIF in any of the cell lines used. These results highlight the widespread distribution and rapid release of LIF in human lung tissue and, in conjunction with our previous report, suggest that this cytokine may play an important role in lung inflammatory processes and neuroimmune interactions.

This article has been cited by other articles:

				D. S. Faffe, L. Flynt, M. Mellema, T. R. Whitehead, K. Bourgeois, R. A. Panettieri Jr., E. S. Silverman, and S. A. Shore Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1{beta} Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1040 - L1048. [Abstract] [Full Text] [PDF]

				R. A. Panettieri Jr. Effects of Corticosteroids on Structural Cells in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 231 - 234. [Abstract] [Full Text] [PDF]

				J. Wang, Q. Chen, J. Corne, Z. Zhu, C. G. Lee, V. Bhandari, R. J. Homer, and J. A. Elias Pulmonary Expression of Leukemia Inhibitory Factor Induces B Cell Hyperplasia and Confers Protection in Hyperoxia J. Biol. Chem., August 15, 2003; 278(33): 31226 - 31232. [Abstract] [Full Text] [PDF]

				T. Fujii, S. Hayashi, J. C. Hogg, R. Vincent, and S. F. Van Eeden Particulate Matter Induces Cytokine Expression in Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 265 - 271. [Abstract] [Full Text] [PDF]

				S. Plisov, K Yoshino, L. Dove, K. Higinbotham, J. Rubin, and A. Perantoni TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis Development, January 4, 2001; 128(7): 1045 - 1057. [Abstract] [PDF]